Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.110
-0.180 (-4.20%)
At close: Apr 2, 2026, 4:00 PM EDT
4.120
+0.010 (0.24%)
After-hours: Apr 2, 2026, 7:43 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $5.89 million as of April 2, 2026. Its market cap has decreased by -32.93% in one year.
Market Cap
5.89M
Enterprise Value
-3.59M
1-Year Change
-32.93%
Ranking
Category
Stock Price
$4.11
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $5.89M, an increase of 18.45%. That is a compound annual growth rate of 1.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 5.89M | -15.84% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 6.36M |
| XTL Biopharmaceuticals | 6.29M |
| Xenetic Biosciences | 6.28M |
| Immuron | 6.27M |
| Artelo Biosciences | 6.19M |
| Ernexa Therapeutics | 6.14M |
| Cardio Diagnostics Holdings | 6.04M |
| Addex Therapeutics | 5.87M |